REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cruvermed S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing | Drugs and Druggists' Sundries Merchant Wholesalers | Health and Personal Care Stores | Pharmacies and Drug Stores | Medical and Diagnostic Laboratories
Full name: Cruvermed S.A. Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Cruvermed S.A. is based in Ecuador, with the head office in Guayaquil. The company operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on July 30, 2021. Cruvermed S.A. currently employs 4 (2023) people. In 2023, the company reported a net sales revenue increase of 2200.51%. Its’ total assets recorded a growth of 222.99%. The enterprise’s net profit margin increased by 29.12% in 2023.

Headquarters
Balsamos Norte 309 , Floor 309
Guayaquil; Guayas;

Contact Details: Purchase the Cruvermed S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Cruvermed S.A. report to view the information.
Outstanding Shares:
Purchase the Cruvermed S.A. report to view the information.
Registered Capital:
Purchase the Cruvermed S.A. report to view the information.
Incorporation Date:
July 30, 2021
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Cruvermed S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
2200.51%▲
Total operating revenue
2202.13%▲
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
18886.72%▲
Total assets
222.99%▲
Total equity
335.47%▲
Operating Profit Margin (ROS)
N/A
Net Profit Margin
29.12%▲
Return on Equity (ROE)
75.37%▲
Quick Ratio
0.08%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo